Data completeness
1/8 — Limited
LOCOID (hydrocortisone butyrate) by Precision BioSciences is clinical pharmacology topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions.
Drug data last refreshed 2h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOCOID (hydrocortisone butyrate) is a topical corticosteroid solution that reduces inflammation, itching, and skin redness through anti-inflammatory and vasoconstrictive mechanisms. It is applied directly to affected skin areas and is absorbed through the epidermis, where it modulates local immune responses. The drug is currently in pre-launch phase under NDA review by sponsor Precision BioSciences.
PRE_LAUNCH
Pre-launch stage indicates opportunity to shape initial commercial strategy; brand team size and scope will depend on approval timing and competitive positioning.
Mechanism of Action
CLINICAL PHARMACOLOGY Topical corticosteroids share anti-inflammatory, anti-pruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on LOCOID at Precision BioSciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.